P1‐263: Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4‐stratified subjects with mild‐to‐moderate Alzheimer's disease
罗格列酮
医学
疾病
临床终点
内科学
临床试验
受体
作者
Claire Alderton,Marina Zvartau‐Hind,Sally Y. Ritchie,Ann M. Saunders,Suzanne Craft,Gary E. Landreth,Ülla Linnamägi,Sharon Sawchak,Michael Gold